Hyperbaric oxygen therapy as an adjunct to the standard wound care for the treatment of diabetic foot ulcers in Indian patients: a cost utility analysis.

Friji Meethale Thiruvoth Subramania Raju RajasulochanaMathan Kumar SSaravanan EParthibane SivananthamSitanshu Sekhar Kar

Published in: Expert review of pharmacoeconomics & outcomes research (2022)

SWC plus HBOT is not cost-effective in India. Additional information is required on patient experiences with adjunctive HBOT, if it were to be adopted as the standard of care in India.

Keyphrases

healthcare
palliative care
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
mental health
prognostic factors
pain management
case report
mesenchymal stem cells
social media
wound healing
combination therapy
health insurance